• Applied Biological Chemistry
• /
• 제51권3호
• /
• pp.238-244
• /
• 2008

층꽃나무 지상부위 정유의 화학성분 구명을 위하여 수증기증류법으로 정유를 얻고, 이를 solid-phase microextraction(SPME)와 headspace(HS)법으로 흡착시킨 다음 CC-MS로 분석하였다. 향취가 fougere, woody한 층꽃나무 정유에는 탄화수소 28종, 알코올 22종, 아세테이트 7종, 케톤 7종, 알데히드 3종, 기타 2종 등 총 69종의 화학성분이 함유되어 있었으며, 다함량 성분은 4,6,6-trimethyl [1S-($1{\alpha},2{\beta},5{\alpha}$)]-bicyclo[3.1.1]hept-3-en-2-ol(11.8%), tau-cadinol(9.4%), myrtenyl acetate(9.2%), pinocarvone(7.0%), 1-hydroxy-1,7-dimethy 1-4-isopropyl-2,7-cyclodecadiene(6.3%), ${\delta}$-3-carene(6.2%)이었다. SPME법으로 흡착 후 분석한 시료에는 탄화수소 22종, 알코올 16종, 아세테이트 6종, 케톤 3종, 에테르 2종 등 총 49종의 화학성분이 검출되었는데, 다량 함유된 성분으로는 ${\delta}$-3-carene(12.6%), (-)-myrtenyl acetate(11.2%), 6,6-dimethyl-2-methylene-bicycol[3.1.1] heptan-3-ol(10.9%), pinocarvone(9.3%)이었다. 그리고 HS법으로 흡착한 다음 분석한 정유에는 탄화수소 5종, 아민 2종, 알코올 1종, 기타 2종 등 총 10종의 화학성분이 검출되었는데, 다량 함유된 성분은 (Z)-2-fluoro-2-butene(34.9%), ${\delta}$-3-carene(6.9%), 6-(4-chlorophenul) tetrahydro-2-methyl-2H-1,2-oxazine(5.9%)이었다. HaCaT 각질형성세포에 미치는 세포독성을 조사하기 위하여 MTT assar를 실시한 결과 층꽃나무 정유의 $IC_{50}$값은 0.011 ${\mu}g/mg$으로 시판 중인 로즈마리 정유나 차나무 정유의 $IC_{50}$값보다 낮았는데, 이러한 결과는 층꽃나무 정유의 상업화를 위해서 더 많은 독성시험이 요구된다는 것을 시사한다.

• Clinical and Experimental Reproductive Medicine
• /
• 제28권4호
• /
• pp.279-286
• /
• 2001

Objective: To elucidate 1) whether there are any differences in the urine concentrations of steroid hormone metabolites between patients with leiomyoma and normal controls 2) the correlation between urinary profiles of steroid hormones and leiomyomas of the uterus according to their type, location, volume, and weight. Materials of Methods : The study population consisted of 37 premenopausal patients with uterine leiomyoma and the control group consisted of 25 premenopausal normal volunteer women without uterine leiomyoma. Confirmation of the existence of uterine leiomyoma was done by ultrasonography and histopathological examination after surgery. The volume of the leiomyoma was estimated by trans-abdominal and/or trans-vaginal ultrasonography. The Leiomyomas were divided into 3 types (subserosal, intramural and submucosal). Seventeen patients had subserosal type of leiomyoma, 10 with the intramural type and 10 with the submucosal type. The locations of the leiomyoma were also divided into 3 groups (fundus, body and isthmus). Seventeen patients showed a fundus location, 10 in body, and 10 in isthmus. We compared urinary profiles of the endogenous steroids between patients with leiomyomas and normal controls, and also investigated the relationship between urinary profiles of the endogenous steroids and leiomyomas according to their type, location, volume and weight by using highly sensitive Gas Chromatography-Mass Spectrometry (GC-MS) system. Results: The mean ages of the patients with leiomyomas and the control group were $43.1{\pm}5.6$ and $40.6{\pm}7.2$ years, the weights were $63.4{\pm}7.3$ and $59.4{\pm}8.1\;kg$, and their heights were $155.4{\pm}4.8$ and $159.3{\pm}4.8\;cm$ respectively. Seventeen patients had subserosal, 10 had intramural, and 10 had submucosal leiomyomas. There were 17 patients with leiomyoma located in fundus, 10 in body and 10 in isthmus. $17{\beta}$-estradiol, 5-AT, 11-keto ET, $11{\beta}$-hydroxy An, $11{\beta}$-hydroxy Et, THS, THA, THE, a-cortolone, a-cortol, $\beta$-cortol, $11{\beta}$-OH Et/$11{\beta}$-OH An and E2/E1 were significantly increased in patients with leiomyoma than in the control group. $17{\beta}$-estradiol was significantly increased in the intramural and the submucosal types than in the subserosal type. There was no significant difference in the concentrations of urinary steroids according to the locations of leiomyomas. There was no significant relationship between the concentration of urinary steroids and the volume of the leiomyomas. $17{\beta}$-estradiol significantly decreased as the weight of uterus increased (r=-0.322, p=0.04). Conclusion: The concentrations of steroid hormone metabolites were generally increased in patients with leiomyoma but were not significantly related to the volume and weight of the leiomyomas. Our study suggests that steroid hormones may be involved in the initiation of leiomyomas but may not be involved in their progression. In addition, the concentrations of steroid hormone metabolites are not related to the leiomyoma type and location.